Wendy Cooper Selected Research

cevipabulin

2/2012

A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wendy Cooper Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 10/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2014
4	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
2	Malignant Mesothelioma 09/2015 - 06/2015
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Glioma (Gliomas) 01/2021
1	Proteinuria 01/2021
1	Hemophilia A (Haemophilia) 01/2021
1	Hemorrhage 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Idiopathic Pulmonary Fibrosis 10/2019
1	Coinfection 02/2016
1	Adenocarcinoma 09/2015

Drug/Important Bio-Agent (IBA)

2	Anaplastic Lymphoma KinaseIBA 10/2018 - 11/2015
2	MicroRNAs (MicroRNA)IBA 09/2015 - 06/2015
2	afliberceptIBA 10/2012 - 01/2010
2	Pharmaceutical PreparationsIBA 02/2012 - 01/2010
1	Rituximab (Mabthera)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	CarbonIBA 10/2019
1	Transfer Factor (Factor, Transfer)IBA 10/2019
1	serum P-component (CIt)IBA 07/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Docetaxel (Taxotere)FDA Link 02/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 12/2015
1	AfatinibIBA 12/2015
1	CrizotinibIBA 11/2015
1	AsbestosIBA 09/2015
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	cevipabulinIBA 02/2012
1	TubulinIBA 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	Biological ProductsIBA 01/2010
1	AngiozymeIBA 10/2005
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2005
1	Catalytic RNA (Ribozymes)IBA 10/2005
1	Carboplatin (JM8)FDA LinkGeneric 10/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2005

Therapy/Procedure

6	Therapeutics 01/2020 - 12/2015
1	Neoadjuvant Therapy 01/2020
1	Drug Therapy (Chemotherapy) 07/2019